Nasolabial fold

Evolus Announces Results from European Head-to-Head Filler Trial

Retrieved on: 
Friday, March 1, 2024
Biotechnology, Pharmaceutical, Surgery, Health, Fitness & Nutrition, Cosmetics, Clinical Trials, Retail, NLF, MD, FDA, Skin, Nasolabial fold, Webcast, Patient, Longevity

Evolus remains on track for the global commercial launch of the first-generation Cold HA Technology in 2025.

Key Points: 
  • Evolus remains on track for the global commercial launch of the first-generation Cold HA Technology in 2025.
  • The filler line will be branded Evolysse™ in the US and Estyme® in the UK and Europe.
  • The Evolysse™/Estyme® Lift filler will be positioned as the most versatile and highest volume filler in the product line.
  • An archived webcast can also be accessed on the Investor Relations page of the Evolus website at www.evolus.com .

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Retrieved on: 
Wednesday, December 20, 2023
Women, Biotechnology, Pharmaceutical, Surgery, Health, Medical Devices, Consumer, Other Health, Partnership, Filler (linguistics), Nasolabial fold, Hyaluronic acid, Lip, Growth, Patient, Neurotoxin, Pharmaceutical industry

As part of the new agreement, Evolus will be licensing its neurotoxin, Nuceiva® (botulinum toxin type A), to Symatese for distribution in France, marking the fifth European market that Evolus has now entered.

Key Points: 
  • As part of the new agreement, Evolus will be licensing its neurotoxin, Nuceiva® (botulinum toxin type A), to Symatese for distribution in France, marking the fifth European market that Evolus has now entered.
  • In addition, Evolus will sub-license its distribution rights for the Estyme® fillers line to a Symatese subsidiary for distribution in France.
  • “We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K. and Europe.
  • In exchange for the exclusive distribution rights in the United Kingdom and Europe, Evolus will issue 610,000 shares of the company’s common stock to Symatese.

MeituEve Teams Up With Scientists From Chinese Academy of Sciences to Find Key Genes That Generate Nasolabial Fold With 3D Skin Analysis Technology

Retrieved on: 
Monday, July 11, 2022
Ageing, Partnership, Chinese Academy of Sciences, Genome-wide association study, Innovation Center station, Biophysics, Face, Method, Hope, Disease, Industry, Education, PLOS, M. A, Algorithm, Engineering, CAS, SID, Wollstein, Nasolabial fold, Dermatology, Shanghai Institute of Technology, ISIC, Eve, International Society, Genetics, IA, ERIC, Gene, Technology, Nutrition, Genetic distance, GLOBE, 3D, Society, Research, GWAS, Deep learning, ISBS, Schürmann, Medical device, Medical imaging, Silviculture, Skin, Science

MeituEve's skin analysis technology is not just a marketing tool for driving sales conversions, but is also a powerful assistant for verifying dermatological research.

Key Points: 
  • MeituEve's skin analysis technology is not just a marketing tool for driving sales conversions, but is also a powerful assistant for verifying dermatological research.
  • During the conference, MeituEve leveraged its expertise in deep learning and image analysis to precisely and accurately detect and quantify facial aging.
  • In this study, novel genes associated with nasolabial folds were found and a strong relationship between skin aging and 3D facial structures was confirmed through genetic research for the first time.
  • This study also showed that MeituEve has a unique advantage in image recognition and grading algorithms for skin analysis.

Galderma to Present New Data From Leading Aesthetics Portfolio and Launch* RESTYLANE® EYELIGHT™ at AMWC 2021

Retrieved on: 
Thursday, September 9, 2021
Health, Surgery, Clinical Trials, General Health, Research, Science

As we advance dermatology for every skin story, we are excited to be delivering novel solutions across our portfolio.

Key Points: 
  • As we advance dermatology for every skin story, we are excited to be delivering novel solutions across our portfolio.
  • Taking the opportunity to engage with a variety of aesthetics and anti-aging experts, Galderma will host a sponsored symposium on Thursday, September 16, 2021, from 14:00-16:00 CEST in the prestigious Prince Pierre Auditorium.
  • The sponsored symposium will be followed on Friday, September 17, 2021, with a bespoke event, For Your Eyes Only, to launch RESTYLANE EYELIGHT, a new solution to combat under-eye shadows.
  • Additional data showcasing the strength and depth of Galdermas pipeline and portfolio will be available throughout AMWC 2021.

Facial Wrinkles/Nasolabial Folds Markets - Global Insights and Forecasts to 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 6, 2021
Health, Other Health, Musicians, Anatomy, Musical instruments, Cosmetics, Nasolabial fold, Wrinkle, Ben Folds

The "Facial Wrinkles/Nasolabial Folds - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Facial Wrinkles/Nasolabial Folds - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.
  • "Facial wrinkles/Nasolabial folds: Disease Insights and Market Forecasts to 2026" report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Facial wrinkles/Nasolabial folds disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Facial wrinkles/Nasolabial folds, drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2026.
  • This section of the report gives the overview of Facial wrinkles/Nasolabial folds disease indication in detail.
  • The section highlights the basic definition, causes and symptoms of disease and details the types of Facial wrinkles/Nasolabial folds disease.

Asia Pacific Facial Fat Transfer Market to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 20, 2020
Surgery, Health, Medicine, Medical specialties, Surgery, Cosmetic surgery, Oral and maxillofacial surgery, Otorhinolaryngology, Rhytidectomy, Plastic surgery, Nasolabial fold, Graft

The "Asia Pacific Facial Fat Transfer Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Facial Fat Transfer Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.
  • Fat transfer, also known as autologous fat transfer or fat grafting, is mostly conducted to improve the aesthetic value of the face by minimizing smile lines or frown lines.
  • As a result, an increase in the incidence of these conditions due to aging and pollution stimulates the demand for a facelift, thus driving the market for facial fat transfer procedures.
  • The visible growth in the number of hospitals and rising healthcare services are expected to support the growth of this region in the facial fat transfer market.

Mary Kay Reveals Breakthrough Anti-Gravity Findings at the 49th European Society for Dermatological Research Meeting

Retrieved on: 
Wednesday, September 18, 2019
Cosmetics, Retail, Catalog, Skin care, Mary Kay, Cosmetics, Kay, Nasolabial fold, Aesthetics, Human body

Mary Kay Inc., a leader in skin care innovation, continues its decades-long commitment to skin science by sharing its latest research targeting the causes and underlying mechanisms of slackened skin at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR) held on September 18-21 in Bordeaux, France.

Key Points: 
  • Mary Kay Inc., a leader in skin care innovation, continues its decades-long commitment to skin science by sharing its latest research targeting the causes and underlying mechanisms of slackened skin at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR) held on September 18-21 in Bordeaux, France.
  • The constant effect of gravity over time contributes to the emergence of prominent nasolabial folds and sagging skin along the jawline and neck.
  • Mary Kay holds more than 1,500 patents for products, technologies, and packaging designs in its global portfolio.
  • Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances.

Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands

Retrieved on: 
Monday, May 21, 2018
Surgery, Medicine, Head, Oral and maxillofacial surgery, Oral surgery, Glycosaminoglycans, Otorhinolaryngology, Restylane, Nasolabial fold, Lyft, Lidocaine

"Restylane Lyft is now the first and only dermal filler with 3 FDA-approved treatment areas the midface/cheek area, nasolabial folds, and now the back of the hands.

Key Points: 
  • "Restylane Lyft is now the first and only dermal filler with 3 FDA-approved treatment areas the midface/cheek area, nasolabial folds, and now the back of the hands.
  • Restylane Lyft was shown to be both safe and well-tolerated, for the correction of volume deficit in the dorsal (back side) hand.
  • Nestl Skin Health's mission is to enhance quality of life by delivering science-based solutions for the health of skin, hair and nails.
  • The Restylane family of products includes Restylane, Restylane-L, Restylane Lyft with Lidocaine, Restylane Silk, Restylane Refyne, and Restylane Defyne.